199 related articles for article (PubMed ID: 20562331)
1. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
Li X; Marcondes AM; Gooley TA; Deeg HJ
Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.
Li X; Xu F; Chang C; Byon J; Papayannopoulou T; Deeg HJ; Marcondes AM
Haematologica; 2013 Mar; 98(3):414-9. PubMed ID: 22983574
[TBL] [Abstract][Full Text] [Related]
3. Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis.
Marcondes AM; Li X; Gooley TA; Milless B; Deeg HJ
Blood; 2010 Mar; 115(10):1993-2002. PubMed ID: 20061558
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.
Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797
[TBL] [Abstract][Full Text] [Related]
5. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
[TBL] [Abstract][Full Text] [Related]
6. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
7. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.
Mhyre AJ; Marcondes AM; Spaulding EY; Deeg HJ
Blood; 2009 Jan; 113(3):649-58. PubMed ID: 18945969
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.
Zang DY; Goodwin RG; Loken MR; Bryant E; Deeg HJ
Blood; 2001 Nov; 98(10):3058-65. PubMed ID: 11698291
[TBL] [Abstract][Full Text] [Related]
9. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
Rajapaksa R; Ginzton N; Rott LS; Greenberg PL
Blood; 1996 Dec; 88(11):4275-87. PubMed ID: 8943864
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.
Xu F; Yang R; Wu L; He Q; Zhang Z; Zhang Q; Yang Y; Guo J; Chang C; Li X
Cancer Lett; 2012 Apr; 317(1):33-40. PubMed ID: 22120066
[TBL] [Abstract][Full Text] [Related]
11. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
[TBL] [Abstract][Full Text] [Related]
12. Twist-1 Enhances Bone Marrow Mesenchymal Stromal Cell Support of Hematopoiesis by Modulating CXCL12 Expression.
Arthur A; Cakouros D; Cooper L; Nguyen T; Isenmann S; Zannettino AC; Glackin CA; Gronthos S
Stem Cells; 2016 Feb; 34(2):504-9. PubMed ID: 26718114
[TBL] [Abstract][Full Text] [Related]
13. High IGFBP-3 levels in marrow plasma in early-stage MDS: effects on apoptosis and hemopoiesis.
Wilson HM; Lesnikov V; Plymate SR; Ward J; Deeg HJ
Leukemia; 2005 Apr; 19(4):580-5. PubMed ID: 15703779
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome.
Vasikova A; Budinska E; Belickova M; Cermak J; Bruchova H
Neoplasma; 2009; 56(4):335-42. PubMed ID: 19469654
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow.
Pecci A; Travaglino E; Klersy C; Invernizzi R
Acta Haematol; 2003; 109(1):29-34. PubMed ID: 12486320
[TBL] [Abstract][Full Text] [Related]
17. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
Hofmann WK; de Vos S; Komor M; Hoelzer D; Wachsman W; Koeffler HP
Blood; 2002 Nov; 100(10):3553-60. PubMed ID: 12411319
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in 'good' versus 'poor' prognosis patients and correlation with apoptosis-related genes.
Tsoplou P; Kouraklis-Symeonidis A; Thanopoulou E; Zikos P; Orphanos V; Zoumbos NC
Leukemia; 1999 Oct; 13(10):1554-63. PubMed ID: 10516757
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
Stirewalt DL; Mhyre AJ; Marcondes M; Pogosova-Agadjanyan E; Abbasi N; Radich JP; Deeg HJ
Br J Haematol; 2008 Feb; 140(4):444-53. PubMed ID: 18162123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
